"Genetic Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc.
Descriptor ID |
D005818
|
MeSH Number(s) |
E05.393.420
|
Concept/Terms |
Genetic Engineering- Genetic Engineering
- Genetic Intervention
- Intervention, Genetic
- Genetic Interventions
- Interventions, Genetic
- Engineering, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Genetic Engineering".
Below are MeSH descriptors whose meaning is more specific than "Genetic Engineering".
This graph shows the total number of publications written about "Genetic Engineering" by people in this website by year, and whether "Genetic Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
1998 | 1 | 1 | 2 |
2003 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
2005 | 0 | 3 | 3 |
2006 | 0 | 1 | 1 |
2007 | 0 | 2 | 2 |
2008 | 1 | 0 | 1 |
2010 | 0 | 2 | 2 |
2011 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2013 | 0 | 2 | 2 |
2015 | 0 | 2 | 2 |
2016 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 3 | 4 |
2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genetic Engineering" by people in Profiles.
-
ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy. J Immunother Cancer. 2020 04; 8(1).
-
Generation of In-Frame Gene Deletion Mutants in Pseudomonas aeruginosa and Testing for Virulence Attenuation in a Simple Mouse Model of Infection. J Vis Exp. 2020 01 08; (155).
-
Advances and opportunities in gene editing and gene regulation technology for Yarrowia lipolytica. Microb Cell Fact. 2019 Nov 29; 18(1):208.
-
CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
-
Oleaginous yeast for biofuel and oleochemical production. Curr Opin Biotechnol. 2019 06; 57:73-81.
-
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest. 2019 02 25; 129(4):1551-1565.
-
Solvent production from xylose. Appl Microbiol Biotechnol. 2018 Oct; 102(20):8707-8715.
-
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors. Cancer Immunol Immunother. 2016 Mar; 65(3):293-304.
-
Engineering Promoter Architecture in Oleaginous Yeast Yarrowia lipolytica. ACS Synth Biol. 2016 Mar 18; 5(3):213-23.
-
Zebrafish lacking functional DNA polymerase gamma survive to juvenile stage, despite rapid and sustained mitochondrial DNA depletion, altered energetics and growth. Nucleic Acids Res. 2015 Dec 02; 43(21):10338-52.